/NKGN
NKGN Stock - NKGen Biotech, Inc. Common Stock
Healthcare|BiotechnologyNASDAQ
$0.05-1.96%
$0.00 (-1.96%) • Dec 19
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.40
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.81
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.06
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NKGN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.05 – $0.05
TARGET (TP)$0.06
STOP LOSS$0.05
RISK/REWARD1:Infinity
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.98
52W High$0.96
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | N/A | N/A | $77,000 | $426,000 |
| Gross Profit | N/A | $-1,203,000 | $59,000 | $396,000 |
| Gross Margin | N/A | N/A | 76.6% | 93.0% |
| Operating Income | $-26,966,000 | $-29,746,000 | $-24,346,000 | $-21,861,000 |
| Net Income | $-44,286,000 | $-82,954,000 | $-26,754,000 | $-23,265,000 |
| Net Margin | N/A | N/A | -34745.5% | -5461.3% |
| EPS | $-1.54 | $-5.38 | $-1.25 | $-1.08 |
Company Overview
Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NKGNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-1.02
Q3 2025
EPS Surprise History
Q2 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q3 24
No data
Q1 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 10, 2025 | — | $-1.02 | — | — |
Q2 2025 | Jun 4, 2025 | — | — | — | — |
Q1 2025 | Mar 4, 2025 | — | $0.15 | — | — |
Q3 2024 | Sep 12, 2024 | — | $-0.67 | — | — |
Q3 2024 | Aug 19, 2024 | — | $-0.67 | — | — |
Q2 2024 | Apr 16, 2024 | — | $-1.68 | — | — |
Q1 2024 | Feb 27, 2024 | — | $-1.54 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-2.48 | — | — |
Q2 2023 | Jun 29, 2023 | — | $-0.11 | — | — |
Q1 2023 | Mar 30, 2023 | — | $0.02 | — | — |
Q4 2022 | Dec 30, 2022 | — | $-0.14 | — | — |
Q3 2022 | Sep 29, 2022 | — | $0.04 | — | — |
Q2 2022 | Jun 29, 2022 | — | $0.22 | — | — |
Q1 2022 | Mar 30, 2022 | — | $0.09 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-0.06 | — | — |
Q3 2021 | Sep 29, 2021 | — | $0.22 | — | — |
Q2 2021 | Jun 29, 2021 | — | $-0.20 | — | — |
Q1 2021 | Mar 30, 2021 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NKGN
What is NKGN's current stock price?
NKGen Biotech, Inc. Common Stock (NKGN) is currently trading at $0.05 per share. The stock has moved -1.96% today.
What is the analyst price target for NKGN?
No analyst price targets are currently available for this stock.
What sector is NKGen Biotech, Inc. Common Stock in?
NKGen Biotech, Inc. Common Stock operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is NKGN's market cap?
NKGen Biotech, Inc. Common Stock has a market capitalization of $0.01 billion, making it a small-cap company.
Does NKGN pay dividends?
No, NKGen Biotech, Inc. Common Stock does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATXI
Avenue Therapeutics, Inc.
$0.65
Mkt Cap: $0.0B
BCTXZ
BriaCell Therapeutics Corp. Warrant
$0.39
Mkt Cap: $0.0B
DRMA
Dermata Therapeutics, Inc.
$2.14
Mkt Cap: $0.0B
ELAB
PMGC Holdings Inc.
$2.26
Mkt Cap: $0.0B
MLEC
Moolec Science S.A.
$0.33
Mkt Cap: $0.0B
NCEL
NewcelX Ltd.
$2.60
Mkt Cap: $0.0B
PTIX
Protagenic Therapeutics, Inc.
$1.19
Mkt Cap: $0.0B
VRAX
Virax Biolabs Group Limited
$0.39
Mkt Cap: $0.0B
WINT
Windtree Therapeutics, Inc.
$0.04
Mkt Cap: $0.0B
XRTX
XORTX Therapeutics Inc.
$0.60
Mkt Cap: $0.0B
Explore stocks similar to NKGN for comparison